Associate Professor, Pathology, Stanford University Sch of Med

Pathology

Dr. Kimberly H. Allison, MD

Kimberly H. Allison practices Pathology. She went to New York Medical College. Kimberly Allison is also a published physician. She has 46 publication published. The most recent publication is: Diagnostic concordance among pathologists interpreting breast biopsy specimens. Kimberly Allison accepts all Medicare patients.

Publications

Diagnostic concordance among pathologists interpreting breast biopsy specimens.
Trends in breast biopsy pathology diagnoses among women undergoing mammography in the United States: A report from the Breast Cancer Surveillance Consortium.
Impact of histological subtype on long-term outcomes of neuroendocrine carcinoma of the breast.
Second opinion in breast pathology: policy, practice and perception.
Initial Results with Preoperative Tattooing of Biopsied Axillary Lymph Nodes and Correlation to Sentinel Lymph Nodes in Breast Cancer Patients.
Digitized Whole Slides for Breast Pathology Interpretation: Current Practices and Perceptions.
Understanding Diagnostic Variability in Breast Pathology: Lessons Learned from an Expert Consensus Review Panel.
Preoperative MRI improves prediction of extensive occult axillary lymph node metastases in breast cancer patients with a positive sentinel lymph node biopsy.
Mouse cursor movement and eye tracking data as an indicator of pathologists' attention when viewing digital whole slide images.
Molecular pathology of breast cancer: what a pathologist needs to know.
Nonmalignant Breast Lesions: ADCs of Benign and High-Risk Subtypes Assessed as False-Positive at Dynamic Enhanced MR Imaging.
A protein complex of SCRIB, NOS1AP and VANGL1 regulates cell polarity and migration, and is associated with breast cancer progression.
Biomarkers of progestin therapy resistance and endometrial hyperplasia progression.
In Vivo Assessment of Ductal Carcinoma in Situ Grade: A Model Incorporating Dynamic Contrast-enhanced and Diffusion-weighted Breast MR Imaging Parameters.
Frequency of HER2 Heterogeneity by Fluorescence In Situ Hybridization According to CAP Expert Panel Recommendations: Time for a New Look at How to Report Heterogeneity.
Lobular In-Situ Neoplasia on Breast Core Needle Biopsy: Imaging Indication and Pathologic Extent Can Identify Which Patients Require Excisional Biopsy.
Endogenous versus tumor-specific host response to breast carcinoma: a study of stromal response in synchronous breast primaries and biopsy site changes.
FOXP3+ regulatory T-cells are abundant in vulvar Paget's disease and are associated with recurrence.
Atypical ductal hyperplasia on vacuum-assisted breast biopsy: suspicion for ductal carcinoma in situ can stratify patients at high risk for upgrade.
The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutations.
Frequency, upgrade rates, and characteristics of high-risk lesions initially identified with breast MRI.
Achieving 95% cross-methodological concordance in HER2 testing: causes and implications of discordant cases.
Complex hyperplasia with and without atypia: clinical outcomes and implications of progestin therapy.
Risk of upgrade of atypical ductal hyperplasia after stereotactic breast biopsy: effects of number of foci and complete removal of calcifications.
Tumor metabolism and blood flow as assessed by positron emission tomography varies by tumor subtype in locally advanced breast cancer.
Frequency and upgrade rates of atypical ductal hyperplasia diagnosed at stereotactic vacuum-assisted breast biopsy: 9-versus 11-gauge.
Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i+) and pN1mi categories.
Immunosuppressive regulatory T cells are associated with aggressive breast cancer phenotypes: a potential therapeutic target.
Estrogen receptor expression in breast cancer: we cannot ignore the shades of gray.
Is surgical excision necessary for focal atypical ductal hyperplasia found at stereotactic vacuum-assisted breast biopsy?
Immunohistochemical markers in endometrial hyperplasia: is there a panel with promise? A review.
Diagnosing endometrial hyperplasia: why is it so difficult to agree?
Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: association with p53 mutations, circulating tumor DNA and survival in women with ovarian ca...
Defining an appropriate threshold for the diagnosis of serous borderline tumor of the ovary: when is a full staging procedure unnecessary?
Alternate molecular genetic pathways in ovarian carcinomas of common histological types.
Epithelioid trophoblastic tumor: review of a rare neoplasm of the chorionic-type intermediate trophoblast.
Accuracy of intraoperative imprint cytology of sentinel lymph nodes in breast cancer.
Superficial malignant peripheral nerve sheath tumor: a rare and challenging diagnosis.
Radiographically occult, diffuse intrasinusoidal hepatic metastases from primary breast carcinomas: a clinicopathologic study of 3 autopsy cases.
Angiosarcoma involving the gastrointestinal tract: a series of primary and metastatic cases.
An unusual case of multiple giant myelolipomas: clinical and pathogenetic implications.
Diffusion tensor magnetic resonance imaging of the normal breast.
Can an immunoassay become a standard technique in detecting oxycodone and its metabolites?
Routine pathologic parameters can predict Oncotype DX recurrence scores in subsets of ER positive patients: who does not always need testing?
Incidence of endometrial hyperplasia.

Schools

New York Medical College
University Of Wa School Of Med

Doctors Specialties

Pathology

Accepted Insurances

Education

University of Washington
New York Medical College

Hospital

Stanford Health Care
UW Medicine/Harborview Medical Center

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Norris B. Finlayson, MD This Doctor is OpenDoctor Recommended.
	Dr. Sharon M. Geaghan, MD This Doctor is OpenDoctor Recommended.
	Dr. Robert S. Ohgami, MD This Doctor is OpenDoctor Recommended.
	Dr. Stuart D. Flynn, MD This Doctor is OpenDoctor Recommended.